Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A study in healthy volunteers and patients with liver cirrhosis to assess the effects of age,
gender, and stable liver disease on the clearance of cholyl-lysyl-fluorescein (NRL972)